文献速递慢阻肺肺结节与肺癌

慢阻肺合并肺癌的免疫与遗传研究进展

[Progress in immunologic and genetic research of chronic obstructive pulmonary disease with lung cancer].
PubMed 文献 · Zhonghua Jie He He Hu Xi Za Zhi · 2022-01-01

本文综述慢阻肺合并肺癌在免疫与遗传两方面的现有研究。免疫角度聚焦中性粒细胞及巨噬细胞的固有免疫、B细胞及T细胞的获得性免疫和氧化应激;遗传角度聚焦遗传易感基因和调控microRNA。旨在为机制研究、诊断和靶向治疗提供方向。

要点

  • 慢阻肺合并肺癌机制复杂,涉及固有免疫、获得性免疫及氧化应激。
  • 遗传角度关注遗传易感基因和microRNA调控。
  • 综述为慢阻肺合并肺癌的机制、诊断和靶向治疗提供方向。

核心结论

  • 慢阻肺合并肺癌机制复杂,需从免疫和遗传多角度理清两者关系。

研究设计与样本

  • 综述,从免疫和遗传角度梳理慢阻肺合并肺癌的现有研究。

主要发现

  • 免疫方面涉及中性粒细胞及巨噬细胞的固有免疫、B细胞及T细胞的获得性免疫和氧化应激。
  • 遗传方面涉及遗传易感基因和调控microRNA。

临床怎么用

  • 为未来慢阻肺合并肺癌的机制研究、诊断和靶向治疗探索提供有益方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic obstructive pulmonary disease (COPD) and lung cancer are two of the respiratory diseases with the highest mortality, which have posed huge threat to human health and brought great burden to society and family. The mechanism of COPD with lung cancer is very complicated. In order to clarify the linkage between these two diseases, this review summarized the present researches of COPD and lung cancer from the aspects of immunology and genetics. The immunologic aspect focused on innate immune of neutrophil and macrophage, adaptive immune of B cell, T cell and oxidative stress. The genetic aspect focused on susceptibility gene and microRNA. Through the thorough elaboration of these researches, we hope to provide useful insights into the further research of mechanism, diagnosis and targeted therapy of COPD with lung cancer. 慢性阻塞性肺疾病(简称慢阻肺)和肺癌是当今病死率最高的两大呼吸系统疾病,给人类健康造成严重威胁,给社会和家庭带来巨大负担。慢阻肺合并肺癌的机制非常复杂,为更好理清两者关系,本文从免疫角度和基因角度对现有研究进行逐一梳理。其中,免疫聚焦中性粒细胞及巨噬细胞的固有免疫和B细胞及T细胞的获得性免疫及氧化应激角度,基因聚焦遗传易感基因和调控microRNA角度。本文全面阐释慢阻肺合并肺癌的机制,以期对未来机制的研究、诊断和靶向治疗等临床方面的探索提供有益方向。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu YH, Ge HY, Zhu HL, et al. [Progress in immunologic and genetic research of chronic obstructive pulmonary disease with lung cancer]. Zhonghua Jie He He Hu Xi Za Zhi. 2022. PMID: 35381639. doi:10.3760/cma.j.cn112147-20211112-00800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。